Answers are grounded in this paper and cite their sources.
Evaluates screening for depression in Parkinson’s disease, suggesting improved clinical outcomes.
To determine the impact of systematic survey-based screening for depression on outcomes in people with Parkinson’s disease (PD) in a clinical practice setting.
No takes yet. Share an insight, caveat, or question.
Super et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: